Therapy News and Research

RSS

Imprivata conducts joint webinar with Carefx on healthcare management

Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it will be conducting a joint webinar with Carefx, a leading provider of interoperable workflow solutions.

12 Oct 2009

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O’Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.

12 Oct 2009

TomoTherapy to present an update on TomoTherapy radiation therapy platform

TomoTherapy Incorporated announced today that it will host an analyst and investor presentation in conjunction with the annual ASTRO (American Society for Radiation Oncology) meeting on Monday, Nov. 2, 2009, at 8:00 a.m. CT.

12 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).

12 Oct 2009

University of Leicester biochemist to present research on the functions of stem cells in the intestine

A University of Leicester Biochemist will present her research on the functions of stem cells in the intestine at a free public lecture.

12 Oct 2009

Depomed announces results from BREEZE 1 and 2 Phase 3 clinical trials of Serada

Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.

12 Oct 2009

Breast cancer patients who achieve pathological complete response have better outcomes

Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.

12 Oct 2009

New journal focuses on therapeutic hypothermia and its applications in cardiology and neurotrauma

Therapeutic Hypothermia, a new online open access peer-reviewed journal, will focus on medical treatment which lowers a patient's body temperature to help reduce the risk of ischemic injury to tissues following a period of insufficient blood flow.

12 Oct 2009

VitalWear partners with XBACK Bracing Services to deliver innovative products

VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that they have formed a partnership with XBACK Bracing Services (www.xbackbrace.com) revolutionizing the bracing and thermal therapy markets. (www.thexbackvwsolution.com)

12 Oct 2009

FDA advisory committee reviews Fibrocell Science's azfibrocel-T for treating wrinkles

Fibrocell Science, Inc. announced today that the U.S. Food and Drug Administration's (FDA) Cellular, Tissue and Gene Therapies Advisory Committee reviewed azfibrocel-T, an autologous cell therapy being investigated for the treatment of moderate to severe nasolabial fold wrinkles in adults.

12 Oct 2009

Detroit jury indicts alleged perpetrators of X-Press Center $2.3M Medicare fraud scheme

Three Miami-Dade County, Fla., residents have been indicted in connection with an alleged $2.3 million Medicare fraud scheme operated out of X-Press Center, a Detroit-area clinic that purported to specialize in providing injection and infusion therapies, Assistant Attorney General of the Criminal Division Lanny A. Breuer, U.S. Attorney for the Eastern District of Michigan Terrence Berg and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS) announced today.

12 Oct 2009

Socioeconomic and geographic disparities in the use of breast-conservating therapy

According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy.

12 Oct 2009

Children can reduce their abdominal pain with guided imagery treatment

Children with functional abdominal pain who used audio recordings of guided imagery at home in addition to standard medical treatment were almost three times as likely to improve their pain problem, compared to children who received standard treatment alone.

12 Oct 2009

AACR to host its first Frontiers in Basic Cancer Research Meeting

The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

Presentations on efficacy of interferon to combat influenza

Amarillo Biosciences, Inc. (ABI) today announced that Professor Dr. Otto Haller from the Department of Virology, Freiburg University, Germany and Professor Dr. Oliver Planz from the Friedrich Loeffler Institute, Tubingen, Germany gave two separate presentations on the efficacy of interferon to combat influenza.

12 Oct 2009

WCMC-Q program highlights the importance of mental health to overall physical health

Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.

12 Oct 2009

Therapy News and Research

Imprivata conducts joint webinar with Carefx on healthcare management

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

TomoTherapy to present an update on TomoTherapy radiation therapy platform

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

University of Leicester biochemist to present research on the functions of stem cells in the intestine

Depomed announces results from BREEZE 1 and 2 Phase 3 clinical trials of Serada

Breast cancer patients who achieve pathological complete response have better outcomes

New journal focuses on therapeutic hypothermia and its applications in cardiology and neurotrauma

VitalWear partners with XBACK Bracing Services to deliver innovative products

FDA advisory committee reviews Fibrocell Science's azfibrocel-T for treating wrinkles

Detroit jury indicts alleged perpetrators of X-Press Center $2.3M Medicare fraud scheme

Socioeconomic and geographic disparities in the use of breast-conservating therapy

Children can reduce their abdominal pain with guided imagery treatment

AACR to host its first Frontiers in Basic Cancer Research Meeting

New technique may lead to more effective treatment for liver disease

Presentations on efficacy of interferon to combat influenza

WCMC-Q program highlights the importance of mental health to overall physical health

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News